Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity
Simple Summary
- Supplementary File 1:
PDF-Document (PDF, 1000 KiB)
Bagratuni, T.; Patseas, D.; Mavrianou-Koutsoukou, N.; Liacos, C.I.; Sklirou, A.D.; Rousakis, P.; Gavriatopoulou, M.; Terpos, E.; Tsitsilonis, O.E.; Trougakos, I.P.; Kastritis, E.; Dimopoulos, M.A. Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity. Cancers 2020, 12, 2864. https://doi.org/10.3390/cancers12102864
Bagratuni T, Patseas D, Mavrianou-Koutsoukou N, Liacos CI, Sklirou AD, Rousakis P, Gavriatopoulou M, Terpos E, Tsitsilonis OE, Trougakos IP, Kastritis E, Dimopoulos MA. Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity. Cancers. 2020; 12(10):2864. https://doi.org/10.3390/cancers12102864
Chicago/Turabian StyleBagratuni, Tina; Patseas, Dimitrios; Mavrianou-Koutsoukou, Nefeli; Liacos, Christine I.; Sklirou, Aimilia D.; Rousakis, Pantelis; Gavriatopoulou, Maria; Terpos, Evangelos; Tsitsilonis, Ourania E.; Trougakos, Ioannis P.; Kastritis, Efstathios; Dimopoulos, Meletios A. 2020. "Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity" Cancers 12, no. 10: 2864. https://doi.org/10.3390/cancers12102864